Neuberger Berman Group »

Monopar Therapeutics shares owned by Neuberger Berman Group

Quarter-by-quarter ownership of Monopar Therapeutics (MNPR) shares owned by Neuberger Berman Group from 13F filings

Historical chart of Neuberger Berman Group investment in Monopar Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Monopar Therapeutics held by Neuberger Berman Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Monopar Therapeutics by Neuberger Berman Group

Quarter filed Position value Share count Share price at filing
2025-12-31 $2.1M 33k 65.30

More positions owned by Neuberger Berman Group

Microsoft Corp Common (MSFT)
Nvidia Corp Common (NVDA)
Apple Common (AAPL)
Amazon Common (AMZN)
Alphabet Inc Class A A Common (GOOGL)
Alphabet Inc-cl C Common (GOOG)
Jan28 Now P @ 120.000000 Option Put Option (NOW)
Jpmorgan Chase & Co Common (JPM)
Eli Lilly & Co Common (LLY)
February 26 Calls on HD US Option Call Option (HD)
Meta Platforms Inc Class A A Common (META)
Broadcom Common (AVGO)
Ishares Core S&p 500 Etf Etf (IVV)
Nextera Energy Common (NEE)
Visa Inc-class A Shares Common (V)

View all positions for Neuberger Berman Group

Top funds holding Monopar Therapeutics

Henderson Group
Adage Capital Partners GP
RA Capital Management
Saturn V Capital Management
Vanguard Group
BlackRock
ADAR1 Capital Management
Wellington Management Company
Siren
Deerfield Management Company
TCG Crossover Management
Polar Capital Holdings
Geode Capital Management
Deep Track Capital
Vivo Capital

View all funds holding Monopar Therapeutics